🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Der zweite Showtag Deutsche Gesellschaft für Kardiologie kann beginnen! Auf dem Programm stehen 1️⃣6️⃣ spannende AGIK Sessions: 🔥 4️⃣ Workshops 📍Saal C 🔥 2️⃣ Sessions speziell für Assistenzpersonal 📍Saal X1 🔥 3️⃣ AGIK Cinema-Sessions📍Saal X3 🔥 7️⃣ interessante Sessions 📍Saal G1 und Saal 3

Toller Vortrag 🔥 mit hilfreichen Einblicken und praktischen Tipps von Elena Repges am Young DGK Stand über die Strukturierung eines Abstracts! Großer Andrang und großes Interesse der Anwesenden. #DGKHerztage Deutsche Gesellschaft für Kardiologie

Spannende Session auf den #DGKHerztage|n zur #TAVI Nachsorge – von paravalvulärer Insuffizienz bis hin zu Schrittmacherstrategien und Endokarditis nach TAVI. 💡 Wertvolle Einblicke von Top-Experten! AGIK Deutsche Gesellschaft für Kardiologie Eike Tigges Erik Rafflenbeul

Among various #myocarditis diagnostic criteria, ESC criteria for clinically suspected myocarditis and updated Lake Louise criteria had the highest prognostic value. bit.ly/4eKsVSl #JACC Christoph Gräni

Hospitation im Hybrid-Op bei einer #TAVI? 🤩🫀 Von Zugangsweg über Prothesenpräparation bis hin zum Verschlusssystem 👀 Alles eine Frage des #Teamwork 🤝 Hier gibt es das ganze Video: youtu.be/Vtb9CuOY1CA?si… Atsushi Sugiura Baravan Al-Kassou | MD Muntadher Al Zaidi Andreas Zietzer @HubrichtD

BREAKING NEWS The 2024 #NobelPrize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.

Our latest publication JAMA Cardiology: We identified 17 #AorticStenosis specific genetic loci, including 5 novel loci. Serum #phosphate is a unique AS risk factor. Our findings reveal AS's distinct pathways from #CAD, paving the way for targeted therapies. ➡️bit.ly/4ezb2pq

Presented at #AHA24: Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: nej.md/3Z5ECOD

A tale of measured and predicted prosthesis-patient-mismatch #PPM after #TAVR - an analysis of the #IMPPACT TAVI registry by Henning Guthoff just published in JACC Journals #JACCInt, accompanied by an editorial of the godfather of PPM Philippe Pibarot bit.ly/3V93T8p 🧵(1/8)

SGLT2i can reduce the incidence of new-onset diabetes among individuals with cardiovascular or kidney disease. Read more in #EHJ 👉 bit.ly/4eMWqTe Rocco Montone EHJ Editor-in-Chief #diabetes

Ihr forscht zum Thema interventionelle Kardiologie? ⬇️EURE CHANCE ⬇️ Noch bis morgen Euer Projekt für den Andreas-Grüntzig-Forschungspreis einreichen ✊ Alle Infos: herzmedizin.de/fuer-aerzte-un… AGIK Young DGK Deutsche Gesellschaft für Kardiologie Philipp Breitbart Tilman Schneider Erik Rafflenbeul Baravan Al-Kassou | MD

In the CLEAR trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results and Research Summary: nej.md/4i2U6dV

Honored to receive a Young Leadership invitation to attend the CRT Meeting 2025. Grateful for this opportunity and excited to engage with fellow leaders and experts at this prestigious event. Looking forward to insightful discussions and learning ahead! CRT Meeting #CRT2025

Prof ron waksman expressing heartfelt gratitude to the incredible CRT Meeting organizing team, who received well-deserved applause from attendees! A fantastic meeting and an unforgettable experience—thank you for making #CRT2024 a success! 👏🏼 #CRTTeam

Fantastic keynote at #CRT2025 by Geoff Martha, Chairman & CEO of #Medtronic, on the challenges & opportunities for Health Tech companies in this uncertain time of change. Even on the last day, the main arena is packed with engaged & motivated attendees. CRT Meeting Medtronic

🎙️NEW #CRT2025 Interview 💫Baravan Al-Kassou | MD discusses insights from the GUARD study on the progression and outcomes of mild to moderate #aortic #stenosis. 📽️Watch here👉 ow.ly/qKqK50VfTz9 #CardioEd #CardioTwitter

Severe multiple valvular heart disease increases mortality after #TAVR, with tricuspid regurgitation posing the highest risk. Read how staged transcatheter edge‐to‐edge repair improves outcomes. #AHAJournals Baravan Al-Kassou | MD Uniklinik Bonn ahajrnls.org/44ohgX1

先日のパリ学会中でのインタビュー JACC cardio. Intervention に掲載された論文の事なんですが、 実は学会で場所が無く、静かな場所を求めて、急遽知人のホテルに転がり込ませてもらって収録した一本

Our latest publication European Journal of Human Genetics on the #genetic architecture of #bicuspid aortic valve (#BAV): Only ~2% of sporadic #BAV patients carry predicted deleterious rare variants in monogenic #BAV genes, suggesting that most #BAV cases are polygenic. bit.ly/4nV9iwB